Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Navidea Biopharmaceuticals Company Profile (NYSE:NAVB)

Consensus Ratings for Navidea Biopharmaceuticals (NYSE:NAVB) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: $2.00 (60.00% upside)

Analysts' Ratings History for Navidea Biopharmaceuticals (NYSE:NAVB)
Show:
DateFirmActionRatingPrice TargetDetailsShare
5/22/2014AegisLower Price Target$2.50 -> $2.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/23/2012 forward)